• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing

My Top Six 2020 Stock Picks Gained an Average of 75%

A few of these names continue to look good in 2021.
By JAMES "REV SHARK" DEPORRE
Dec 30, 2020 | 11:08 AM EST
Stocks quotes in this article: AUPH, PSNL, TPX, REPH, DDOG, INMD, ARKG

Back in early 2020, I picked six stocks that I thought would perform well in 2020. The six names were Aurinia Pharmaceuticals (AUPH) , Personalis (PSNL) , Tempur Sealy (TPX) , Recro Pharmaceuticals (REPH) , Datadog (DDOG) , and InMode (INMD) .

If I had foreseen a pandemic I probably would have changed some of my picks but overall they did quite well with an average gain of 75%. I still like AUPH, PSNL, and INMD in the year ahead. Here is how they have performed:

PSNL up 273%. This was a name that had a great story in the cancer genomic testing area but went unrecognized for a long time. It was finally discovered and jumped in the last few months due in part to aggressive buying by the ARK Genomic Revolution Multi-Sector ETF (ARKG) . It is still a great story and probably a potential acquisition play but it's no longer cheap and will need to perform well to keep running

DDOG up 166%. DDOG is a cloud play that benefited from the 'work at home' theme this year. The company assists in monitoring the operation of software and provides analytics. It has had tremendous revenue growth but it is very expensive and will need to continue to put up big numbers. I would buy this only after a deeper pullback.

TPX up 27%. TPX took a big hit as retail sales of bedding products dropped sharply when the Covid crisis hit but it recovered very well. Sales grew 38% in the third quarter and it still looks relatively cheap. This is not a momentum name but should be solid stock in the year ahead.

INMD up 21%. INMD provides devices for minimally-invasive aesthetic procedures. Its business dropped sharply but is roaring back with strong eps and revenue in the third quarter and predicted eps growth of 25% in 2021. I believe this business still has substantial upside and should see some good gains in 2021.

AUPH down 30%. AUPH is a classic example of a stock with good news but not yet appreciated by the market. It made substantial progress in the development of its drug for the treatment of lupus nephritis but the market is waiting for FDA approval which is expected in late January. I believe this stock will see increased interest as the FDA decision approaches.

REPH down 84%. The big loser was REPH which is a contract manufacturer of pharmaceuticals. My view was that there was an increased focus on shifting drug manufacturing to the U.S. but management simply failed to perform. The stock has recently recovered but still has much to prove before I'd be interested again.

The most important lesson from these picks is that it is good to have some diversification. The winners more than offset the two losers.

I'll have some new picks for 2021 coming soon.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, James "Rev Shark" DePorre was Long PSNL, AUPH, INMD.

TAGS: Economy | Investing | Markets | Stocks | Trading | Coronavirus

More from Investing

Jumping Juniper Networks? How to Play the Stock That Looks Ready to Rally

Bruce Kamich
Mar 27, 2023 3:24 PM EDT

Let's check out the charts and indicators.

3 Unduly Punished High-Yield Bank Stocks to Buy

Bob Ciura
Mar 27, 2023 2:42 PM EDT

These names offer investors sustainable dividend yields of 5%+ alongside attractive share price upside potential.

Could Pioneer Natural Resources Rally Soon?

Bruce Kamich
Mar 27, 2023 1:58 PM EDT

Here's what aggressive traders could do.

Take a Fresh Look at Where You Put Your Cash

Peter Tchir
Mar 27, 2023 12:40 PM EDT

Let's get back to the basics of cash reallocation and see why I'm not freaking out, but I'm also not in a mood for risk.

Let's 'Triangulate' Costco's Breakout Potential

Bruce Kamich
Mar 27, 2023 12:14 PM EDT

Shares of them membership have outlined a really large triangle formation. Here's which way the stock is leaning.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 04:00 PM EDT CHRIS VERSACE

    AAP Podcast: This Solar Company Is a Head-Turner

    Listen to my interview with Brian Roth, CEO of sol...
  • 01:56 PM EDT PETER TCHIR

    Very Cautious

    I am very cautious here. I don't like how the c...
  • 08:58 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    How to Adjust Your Trading Style as Market Conditi...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login